Table:
Univariate Analysis	Multivariate Analysis
Variable	HR (95% CI)	p-value	HR (95% CI)	p-value
Age > 65	1.44 (0.64–2.43)	0.58	NA	NA
Male sex	2.23 (1.42–3.05)	0.01	3.66 (1.56–8.60)	0.002
G3 vs G1G2 vs G1	1.36 (0.58–3.21)0.33 (0.03–2.92)	0.290.32	NA	NA
T3-T4 vs T1-T2	1.94 (0.88–4.25)	0.12	NA	NA.
N + ve vs N -ve	2.11 (1.31–2.90)	0.02	2.25 (1.00–5.17)	0.049
RT total dose	1.42 (0.87–2.33)	0.16	NA	NA
Boost: yes vs no	1.72 (0.40–7.35)	0.47	NA	NA
OTT > 42 days	1.75 (0.86–2.65)	0.19	NA	NA
Hb	0.5 (0.30–0.83)	0.006	0.53 (0.33–0.87)	0.001
Response	6.26 (2.73–14.40)	< 0.0001	6.96 (2.96–16.50)	< 0.0001

Render the table in Markdown format.

|  | <COLSPAN=2> Univariate Analysis | <COLSPAN=2> Multivariate Analysis | 
 | Variable | HR (95% CI) | p-value | HR (95% CI) | p-value | 
 | --- | --- | --- | --- | --- | 
 | Age > 65 | 1.44 (0.64–2.43) | 0.58 | NA | NA | 
 | Male sex | 2.23 (1.42–3.05) | 0.01 | 3.66 (1.56–8.60) | 0.002 | 
 | G3 vs G1G2 vs G1 | 1.36 (0.58–3.21)0.33 (0.03–2.92) | 0.290.32 | NA | NA | 
 | T3-T4 vs T1-T2 | 1.94 (0.88–4.25) | 0.12 | NA | NA. | 
 | N + ve vs N -ve | 2.11 (1.31–2.90) | 0.02 | 2.25 (1.00–5.17) | 0.049 | 
 | RT total dose | 1.42 (0.87–2.33) | 0.16 | NA | NA | 
 | Boost: yes vs no | 1.72 (0.40–7.35) | 0.47 | NA | NA | 
 | OTT > 42 days | 1.75 (0.86–2.65) | 0.19 | NA | NA | 
 | Hb | 0.5 (0.30–0.83) | 0.006 | 0.53 (0.33–0.87) | 0.001 | 
 | Response | 6.26 (2.73–14.40) | < 0.0001 | 6.96 (2.96–16.50) | < 0.0001 |